Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to advance cancer therapy ...
Business Wire

Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications

SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologie…

The optical genome mapping market is poised for substantial growth, expanding from $0.23 billion in 2025 to $0.29 bi ...